Invention Grant
- Patent Title: Anti-cancer phosphorothioate-coupled peptide conjugates and methods of using the same
-
Application No.: US16630347Application Date: 2018-07-13
-
Publication No.: US11607457B2Publication Date: 2023-03-21
- Inventor: Andreas Herrmann , Hua Yu , Yanwen Fu
- Applicant: CITY OF HOPE , Sorrento Therapeutics, Inc.
- Applicant Address: US CA Duarte; US CA San Diego
- Assignee: CITY OF HOPE,Sorrento Therapeutics, Inc.
- Current Assignee: CITY OF HOPE,Sorrento Therapeutics, Inc.
- Current Assignee Address: US CA Duarte; US CA San Diego
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- International Application: PCT/US2018/042179 WO 20180713
- International Announcement: WO2019/014650 WO 20190117
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/04 ; A61K47/54 ; A61P35/00

Abstract:
Provided herein are, inter alia, nucleic acid-peptide conjugates including a non-cell penetrating protein (e.g., an Hdm2 targeting peptide) attached at its C-terminus to a phosphorothioate nucleic acid. Attachment of the phosphorothioate nucleic acid to the non-cell penetrating protein conveys stability to and allows for efficient intracellular delivery of the non-cell penetrating peptide. The nucleic acid-peptide conjugates provided herein including embodiments thereof are useful, inter alia, for the treatment of cancer.
Public/Granted literature
- US20210154305A1 ANTI-CANCER PHOSPHOROTHIOATE-COUPLED PEPTIDE CONJUGATES AND METHODS OF USING THE SAME Public/Granted day:2021-05-27
Information query